New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - metoprolol succinate 23.75mg;   - modified release tablet - 23.75 mg - active: metoprolol succinate 23.75mg   excipient: ethylcellulose hydrated silica hyprolose hypromellose liquid paraffin macrogol 6000 microcrystalline cellulose sodium stearyl fumarate titanium dioxide - · hypertension. to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. · angina pectoris. · symptomatic mild to severe chronic heart failure as an adjunct to other heart failure therapy to: increase survival, reduce hospitalisation, improve left ventricular function, improve new york heart association (nyha) functional class and improve quality of life. · cardiac arrhythmias, especially supraventricular tachycardia, reduction of ventricular rate in atrial fibrillation and ventricular extrasystoles. · maintenance treatment after myocardial infarction · hyperthyroidism. · functional heart disorder with palpitations. · migraine prophylaxis. · paediatric hypertension

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - metoprolol tartrate 1 mg/ml;   - solution for injection - 1 mg/ml - active: metoprolol tartrate 1 mg/ml   excipient: sodium chloride water for injection - betaloc iv is indicated for the following indications: · cardiac arrhythmias, especially supraventricular tachycardia, reduction of ventricular rate in atrial fibrillation and ventricular extrasystoles. · suspected or definite myocardial infarction.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - metoprolol tartrate -

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - metoprolol tartrate; metoprolol tartrate - solution for injection - 1 milligram(s)/millilitre - beta blocking agents, selective; metoprolol

Canada - English - Health Canada

astrazeneca canada inc - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents

Canada - English - Health Canada

astrazeneca canada inc - metoprolol tartrate - tablet - 50mg - metoprolol tartrate 50mg - beta-adrenergic blocking agents

Canada - English - Health Canada

astrazeneca canada inc - metoprolol tartrate - solution - 1mg - metoprolol tartrate 1mg - beta-adrenergic blocking agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

recordati pharmaceuticals ltd - metoprolol tartrate - solution for injection - 1mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

recordati ireland limited - metoprolol tartrate - solution for injection - 1 milligram(s)/millilitre - beta blocking agents, selective; metoprolol

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - metoprolol tartrate -